| Caregivers Home Health | |
| 19999 St Josephs Drive, Centerville, Iowa 52544 | |
| (641) 437-1117 | |
| Name | Caregivers Home Health |
|---|---|
| Location | 19999 St Josephs Drive, Centerville, Iowa |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Home Health Aide |
| Medicare ID | 167423 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 50060, 50138, 52501, 52530, 52531, 52536, 52537, 52544, 52549, 52553, 52554, 52555, 52560, 52561, 52566, 52569, 52571, 52572, 52574, 52577, 52581, 52584, 52590, 53531 |
| NPI Number | 1710253497 |
| Organization Name | CAREGIVERS HOME HEALTH, LLC |
| Address | 19999 Saint Josephs Drive, Centerville, IA 52544 |
| Phone Number | 641-437-1117 |
News Archive
A new preprint on the medRxiv server supports the role of vaccination in reducing the rate of symptomatic coronavirus disease 2019 (COVID-19).
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.
College student marijuana use continues its nearly decade-long increase, according to the most recent national Monitoring the Future study.
› Verified 3 days ago
| Quality Rating: |
News Archive
A new preprint on the medRxiv server supports the role of vaccination in reducing the rate of symptomatic coronavirus disease 2019 (COVID-19).
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.
College student marijuana use continues its nearly decade-long increase, according to the most recent national Monitoring the Future study.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 97.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 94.3 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.7 | 99.6 |
| How often the home health team checked patients for depression | 99.1 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 84.3 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 86.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 92.9 | 96.4 |
News Archive
A new preprint on the medRxiv server supports the role of vaccination in reducing the rate of symptomatic coronavirus disease 2019 (COVID-19).
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.
College student marijuana use continues its nearly decade-long increase, according to the most recent national Monitoring the Future study.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 81.5 | 79.6 |
| How often patients got better at getting in and out of bed | 75.8 | 81.1 |
| How often patients got better at bathing | 84.6 | 82.3 |
| How often patients’ breathing improved | 71.6 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 81.5 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 61.1 | 75 |
| How often home health patients had to be admitted to the hospital | 12.4 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 22.1 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 94.4 | 94 |
News Archive
A new preprint on the medRxiv server supports the role of vaccination in reducing the rate of symptomatic coronavirus disease 2019 (COVID-19).
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.
College student marijuana use continues its nearly decade-long increase, according to the most recent national Monitoring the Future study.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
A new preprint on the medRxiv server supports the role of vaccination in reducing the rate of symptomatic coronavirus disease 2019 (COVID-19).
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.
College student marijuana use continues its nearly decade-long increase, according to the most recent national Monitoring the Future study.
› Verified 3 days ago
The patient survey data of Caregivers Home Health is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 88 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 85 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 81 | 78 |
News Archive
A new preprint on the medRxiv server supports the role of vaccination in reducing the rate of symptomatic coronavirus disease 2019 (COVID-19).
Pfizer Inc. announced today top-line results from two Phase 3 clinical trials of tofacitinib, a novel, oral Janus kinase inhibitor that is being investigated for the treatment of adults with moderate-to-severe chronic plaque psoriasis: OPT Compare (A3921080) and OPT Retreatment (A3921111).
The American Society of Clinical Oncology today announced results from four major studies to be presented at ASCO's 51st Annual Meeting, May 29-June 2, in Chicago. Findings showed that use of a widely available vitamin pill reduces the risk of non-melanoma skin cancers; that early chemotherapy extends the lives of men with advanced prostate cancers; and that new therapies can improve outcomes for children with a rare form of kidney cancer and adults with relapsed multiple myeloma.
College student marijuana use continues its nearly decade-long increase, according to the most recent national Monitoring the Future study.
› Verified 3 days ago
Caregivers Home Health Location: 19999 St Josephs Drive, Centerville, Iowa 52544 Ratings: Phone: (641) 437-1117 |